Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Corixa [CRXA] - cancer vaccines -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (79)	6/5/2001 5:00:22 PM
From: ewolf	Read Replies (1) \| Respond to of 222

Sure that the rise has a lot to do with sector strength and crxa vaccine program. They said they would resubmit their application some time this month. If they do, their credibility would certainly be much stronger. Seems to me that the drug approval process is rarely smooth which is why I was surprised that you soured on the company given your belief in the drug and the fact that efficacy doesn't appear to be an issue. Set up somewhat similar to Aviron where manufacturing was the main problem. Thanks for your input. eaw